4 research outputs found

    The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis

    No full text
    <p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s12325-017-0484-0"><b>here</b>.</a><br> <br> <strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>[email protected]</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides<u></u></p

    Additional file 1: Appendix A. of Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA

    No full text
    Eligibility criteria. Appendix B. MEDLINE search strategy. Appendix C. Excluded studies. Appendix D. WinBUGS code. Appendix E. Similarity assessment. Appendix F. Results of the random-effects analyses. (DOCX 247 kb

    Additional file 1: of Updated systematic review: associations between proximity to animal feeding operations and health of individuals in nearby communities

    No full text
    Discussion about other outcomes included in the systematic review. Excel Spreadsheet with extracted data from review. Data extraction forms, risk of bias forms and search startergies used for review. Figure S1. Neurological and psychological symptoms and stress outcomes for which the effect size was reported as an odds ratio. Figure S2. Neurological symptoms for which the effect size was reported as a regression coefficient. Figure S3. Psychological outcomes for which the effect size was reported as a point estimate of the mean difference. Figure S4. Psychological outcomes for which the effect size was reported as a point estimate. Figure S5. Psychological outcomes for which the effect size was reported as a regression coefficient. Figure S6. Dermatologic, otologic, and optical outcomes for which the effect size was reported as a regression coefficient. Figure S7. Gastrointestinal and “Other” outcomes for which the effect size was reported as a regression coefficient (β). Figure S8. Stress outcomes for which the effect size was reported as a regression coefficient (β). Figure S9. Lower respiratory outcomes for which the effect size was reported as a prevalence ratio. (ZIP 1.40 mb
    corecore